Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceutical Marketing and Terminal Procurement	3.39B	-	-	-	-
Pharmaceutical Retail	4.01B	-	2.61B	2.23B	1.56B
Pharmaceutical Retail Growth	-	-	16.94%	43.19%	-
Other	18.91M	-	-	-	-
Offset of Business	-2.13B	-	-	-	-
Industrial Production	197.69M	-	77.74M	-	-
Pharmaceutical Agent	-	-	742.32M	733.76M	588.31M
Pharmaceutical Agent Growth	-	-	1.17%	24.72%	-
Terminal Collection	-	-	291.35M	233.64M	121.06M
Terminal Collection Growth	-	-	24.70%	93.00%	-
Information Service	-	-	418.63K	1.65M	636.11K
Information Service Growth	-	-	-74.62%	159.26%	-
Unallocated Other Operating Income	-	-	74.42M	60.74M	69.46M
Unallocated Other Operating Income Growth	-	-	22.53%	-12.55%	-
Total	5.49B	-	3.80B	3.26B	2.34B
Total Growth	-	-	16.39%	39.50%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
East China	4.42B	3.67B	3.06B	2.63B	-
East China Growth	20.26%	19.97%	16.20%	-	-
South China	82.55M	70.75M	62.53M	50.05M	-
South China Growth	16.68%	13.13%	24.95%	-	-
Central China	167.53M	150.11M	132.97M	113.42M	-
Central China Growth	11.61%	12.89%	17.23%	-	-
North China	159.32M	122.44M	93.69M	88.97M	-
North China Growth	30.12%	30.69%	5.30%	-	-
North-east Area	217.40M	175.04M	156.19M	135.27M	-
North-east Area Growth	24.20%	12.07%	15.47%	-	-
North-west Region	126.89M	89.63M	71.49M	66.45M	-
North-west Region Growth	41.56%	25.39%	7.57%	-	-
Southwest Region	202.52M	170.20M	143.88M	113.85M	-
Southwest Region Growth	18.99%	18.29%	26.37%	-	-
Overseas	5.77M	4.09M	1.55M	-	-
Overseas Growth	41.18%	164.13%	-	-	-
Unallocated	109.08M	77.81M	74.42M	60.74M	-
Unallocated Growth	40.19%	4.55%	22.53%	-	-
China	-	-	-	-	2.34B
China Growth	-	-	-	-	21.12%
Total	5.49B	4.53B	3.80B	3.26B	2.34B
Total Growth	21.07%	19.34%	16.39%	39.50%	21.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error